title: Parsonage-Turner syndrome following post-exposure prophylaxis.
abstract: BACKGROUND
  The 'Parsonage-Turner syndrome' (PTS) is a rare but distinct disorder with an abrupt onset of shoulder pain, followed by weakness and atrophy of the upper extremity musculature, and a slow recovery requiring months to years. To our best knowledge, this is the first case describing symptoms and signs of PTS following the administration of a post-exposure prophylaxis (PEP) regimen against possible human immunodeficiency virus (HIV) and hepatitis B virus (HBV) infection.
  
  
  METHODS
  A 25-year-old Caucasian man presented with pain and unilateral scapular winging following PEP against possible HIV and HBV infection. Although atrophy and weakness were observed for the right supraspinatus muscle, a full range of motion was achievable. Neurological examination, plain radiography of the right shoulder and electromyography showed no additional abnormalities. The patient was diagnosed with post-vaccination PTS and treated non-operatively. During the following 15 months the scapular winging receded and full muscle strength was regained.
  
  
  CONCLUSIONS
  Parsonage-Turner syndrome is a rare clinical diagnosis. The precise pathophysiological mechanism of PTS remains unclear, but it seems to involve an interaction between genetic predisposition, mechanical vulnerability and an autoimmune trigger. An immunological event, such as - in this case - a vaccination as part of PEP treatment, can trigger the onset of PTS. The clinical presentation is distinctive with acute severe pain followed by patchy paresis, atrophy and sensory symptoms that persist for months to years. No currently available tests can provide a definite confirmation or exclusion of PTS. Routine blood examination, electromyography (EMG), and computed tomography (CT) or magnetic resonance imaging (MRI) serve mainly to exclude other disorders. The recovery can be quite lengthy, non-operative treatment is the accepted practice. Supplementary administration of oral prednisolone could shorten the duration of pain. Although the outcome is typically preferable, a substantial amount of patients are left with some residual paresis and functional impairment.
authors.forename: Duncan P
authors.initials: DP
authors.lastname: Fransz
authors.affiliation: Department of Orthopaedic Surgery, VU University Medical Center, PO Box 7057, 1007 MB Amsterdam, The Netherlands. c.schonhuth@vumc.nl.
authors.forename: Casper P
authors.initials: CP
authors.lastname: Schönhuth
authors.forename: Tjeerd J
authors.initials: TJ
authors.lastname: Postma
authors.forename: Barend J
authors.initials: BJ
authors.lastname: van Royen
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects*; D001696:Biomechanical Phenomena; D020968:Brachial Plexus Neuritis / Q000139:chemically induced* / Q000175:diagnosis / Q000503:physiopathology / Q000628:therapy; D060085:Coinfection; D015658:HIV Infections / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D006509:Hepatitis B / Q000175:diagnosis / Q000276:immunology / Q000517:prevention & control*; D017325:Hepatitis B Vaccines / Q000009:adverse effects*; D006801:Humans; D008297:Male; D056990:Post-Exposure Prophylaxis; D020127:Recovery of Function; D012307:Risk Factors; D012782:Shoulder / Q000503:physiopathology*; D016896:Treatment Outcome; D014611:Vaccination / Q000009:adverse effects
chemical_list: D000998:Antiviral Agents; D017325:Hepatitis B Vaccines
references.citation: J Bone Joint Surg Am. 1996 Sep;78(9):1405-8
references.pmid: 8816659
references.citation: Vaccine. 2008 Aug 18;26(35):4417-9
references.pmid: 18602437
references.citation: Clin Pediatr (Phila). 1973 Aug;12(8):506-7
references.pmid: 4725896
references.citation: Pediatrics. 1997 Apr;99(4):602-3
references.pmid: 9093307
references.citation: Radiology. 2006 Aug;240(2):501-7
references.pmid: 16864674
references.citation: BMJ Case Rep. 2012 Nov 28;2012:
references.pmid: 23192585
references.citation: Ann Intern Med. 1987 Dec;107(6):849-51
references.pmid: 3688679
references.citation: J Neurol Neurosurg Psychiatry. 2011 Jun;82(6):707-8
references.pmid: 20710009
references.citation: Int J STD AIDS. 2012 Feb;23(2):143-4
references.pmid: 22422693
references.citation: J Neurol. 2007 Jun;254(6):695-704
references.pmid: 17446996
references.citation: Brain. 2006 Feb;129(Pt 2):438-50
references.pmid: 16371410
references.citation: Arch Neurol. 1977 Aug;34(8):518
references.pmid: 889491
references.citation: Am J Epidemiol. 1988 Feb;127(2):337-52
references.pmid: 2962488
references.citation: Am J Phys Med Rehabil. 2009 Nov;88(11):941-6
references.pmid: 19404188
references.citation: Muscle Nerve. 1990 May;13(5):461
references.pmid: 2345565
references.citation: World Neurol. 1961 Nov;2:973-9
references.pmid: 13864958
references.citation: Clin Orthop Relat Res. 2008 Mar;466(3):652-60
references.pmid: 18196359
references.citation: Curr Rev Musculoskelet Med. 2008 Mar;1(1):1-11
references.pmid: 19468892
references.citation: Arch Neurol. 1972 Aug;27(2):109-17
references.pmid: 4339239
references.citation: Int J STD AIDS. 2012 Feb;23(2):145-6
references.pmid: 22422694
references.citation: JAMA. 1994 May 25;271(20):1602-5
references.pmid: 8182813
references.citation: Hand (N Y). 2011 Dec;6(4):454-6
references.pmid: 23204977
references.citation: Nat Rev Neurol. 2011 May 10;7(6):315-22
references.pmid: 21556032
references.citation: Clin Orthop Relat Res. 1999 Nov;(368):37-43
references.pmid: 10613151
references.citation: BMC Musculoskelet Disord. 2007 Mar 07;8:25
references.pmid: 17343759
references.citation: Ann Indian Acad Neurol. 2011 Oct;14(4):272-8
references.pmid: 22346016
references.citation: Cochrane Database Syst Rev. 2009 Jul 08;(3):CD006976
references.pmid: 19588414
references.citation: Lancet. 1948 Jun 26;1(6513):973-8
references.pmid: 18866299
references.citation: J Infect. 2008 Jul;57(1):88-90
references.pmid: 18514915